APO Research
Talk to an analyst

APO RESEARCH · REPORT

Bendamustine

Bendamustine is a chemotherapy medication used in the treatment of chronic lymphocytic leukemia (CLL), multiple myeloma, and non-Hodgkin's lymphoma. It is given by injection into a vein.

Explore the product
View pricing & licenses

Product & engineering

Understand the product.

Bendamustine is a chemotherapy medication used in the treatment of chronic lymphocytic leukemia (CLL), multiple myeloma, and non-Hodgkin's lymphoma. It is given by injection into a vein.

Selected research

Industry Growth & Trends

Global Bendamustine Industry Growth and Trends Forecast to 2032

1 January 202695 pages

Choose your research edition.

Industry ResearchBendamustine Industry Research Report 2026117 pages · $2,950 USDIndustry Growth & TrendsGlobal Bendamustine Industry Growth and Trends Forecast to 203295 pages · $3,450 USDMarket StructureGlobal Bendamustine Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032189 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Bendamustine Market Outlook and Growth Opportunities 2026194 pages · $4,250 USDMarket Analysis & ForecastGlobal Bendamustine Market Analysis and Forecast 2026-2032195 pages · $4,950 USD

Market perspective

Bendamustine is a chemotherapy medication used in the treatment of chronic lymphocytic leukemia (CLL), multiple myeloma, and non-Hodgkin's lymphoma. It is given by injection into a vein.

Market competition is intense. Teva, Eisai, Eagle Pharmaceuticals, MundiPharma, Mylan, Natco Pharma, Emcure, etc. are the leaders of the industry, with Teva occupies the major markets share of over 83% in 2018.

Report Scope

Read the full market overview

This report provides a structured, data-driven view of the global Bendamustine market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The Bendamustine market size, estimates, and forecasts are presented in terms of sales volume (K Units) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Bendamustine market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Bendamustine.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading manufacturers in the global Bendamustine market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

Bendamustine Market by Company

Teva

Eisai

Eagle Pharmaceuticals

MundiPharma

Mylan

Natco Pharma

Emcure

Miracalus Pharma

Bendamustine Segment by Type

25mg Injection

100mg Injection

Others

Bendamustine Segment by Application

Chronic Lymphocytic Leukemia

Multiple Myeloma

Non-Hodgkin's Lymphoma

Bendamustine Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Bendamustine market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Bendamustine and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Bendamustine.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Bendamustine manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Sales, revenue of Bendamustine in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.

Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.

Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.

Chapter 13: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Major Company of 25mg Injection Table 2. Major Company of 100mg Injection Table 3. Major Company of Others Table 4. Global Bendamustine Sales by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 5. Global Bendamustine Sales by Type (2021-2026) & (K Units) Table 6. Global Bendamustine Sales Market Share in Volume by Type (2021-2026) Table 7. Global Bendamustine Sales by Type (2021-2026) & (US$ Million) Table 8. Global Bendamustine Sales Market Share in Value by Type (2021-2026) Table 9. Global Bendamustine Price by Type (2021-2026) & (USD/Unit) Table 10. Global Bendamustine Sales by Type (2027-2032) & (K Units) Table 11. Global Bendamustine Sales Market Share in Volume by Type (2027-2032) Table 12. Global Bendamustine Sales by Type (2027-2032) & (US$ Million) Table 13. Global Bendamustine Sales Market Share in Value by Type (2027-2032) Table 14. Global Bendamustine Price by Type (2027-2032) & (USD/Unit) Table 15. North America Bendamustine Sales by Type (2021-2026) & (K Units) Table 16. North America Bendamustine Sales by Type (2021-2026) & (US$ Million) Table 17. Europe Bendamustine Sales by Type (2021-2026) & (K Units) Table 18. Europe Bendamustine Sales by Type (2021-2026) & (US$ Million) Table 19. Asia-Pacific Bendamustine Sales by Type (2021-2026) & (K Units) Table 20. Asia-Pacific Bendamustine Sales by Type (2021-2026) & (US$ Million) Table 21. Latin America Bendamustine Sales by Type (2021-2026) & (K Units) Table 22. Latin America Bendamustine Sales by Type (2021-2026) & (US$ Million) Table 23. Middle East and Africa Bendamustine Sales by Type (2021-2026) & (K Units) Table 24. Middle East and Africa Bendamustine Sales by Type (2021-2026) & (US$ Million) Table 25. Bendamustine Industry Trends Table 26. Bendamustine Industry Drivers Table 27. Bendamustine Industry Opportunities and Challenges Table 28. Bendamustine Industry Restraints Table 29. Global Bendamustine Sales Revenue by Company (US$ Million) & (2021-2026) Table 30. Global Bendamustine Revenue Market Share by Company (2021-2026) Table 31. Global Bendamustine Sales by Company (2021-2026) & (K Units) Table 32. Global Bendamustine Sales Share by Company (2021-2026) Table 33. Global Bendamustine Market Price by Company (2021-2026) & (USD/Unit) Table 34. Global Bendamustine Industry Company Ranking, 2024 VS 2025 VS 2026 Table 35. Global Bendamustine Major Company Production Sites and Headquarters Table 36. Global Bendamustine Company, Product Type & Application Table 37. Global Bendamustine Company Establishment Date Table 38. Global Company Market Concentration Ratio (CR5 and HHI) Table 39. Global Bendamustine by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 40. Global Bendamustine Market Size Comparison by Region (US$ Million): 2021 VS 2025 VS 2032 Table 41. Global Bendamustine Sales by Region (2021-2026) & (K Units) Table 42. Global Bendamustine Sales Market Share in Volume by Region (2021-2026) Table 43. Global Bendamustine Sales by Region (2021-2026) & (US$ Million) Table 44. Global Bendamustine Sales Market Share in Value by Region (2021-2026) Table 45. Global Bendamustine Sales (K Units), Value (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 46. Global Bendamustine Sales by Region (2027-2032) & (K Units) Table 47. Global Bendamustine Sales Market Share in Volume by Region (2027-2032) Table 48. Global Bendamustine Sales by Region (2027-2032) & (US$ Million) Table 49. Global Bendamustine Sales Market Share in Value by Region (2027-2032) Table 50. Global Bendamustine Sales (K Units), Value (US$ Million), Price (USD/Unit) and Gross Margin (2027-2032) Table 51. Global Bendamustine Sales by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 52. Global Bendamustine Sales by Application (2021-2026) & (K Units) Table 53. Global Bendamustine Sales Market Share in Volume by Application (2021-2026) Table 54. Global Bendamustine Sales by Application (2021-2026) & (US$ Million) Table 55. Global Bendamustine Sales Market Share in Value by Application (2021-2026) Table 56. Global Bendamustine Price by Application (2021-2026) & (USD/Unit) Table 57. Global Bendamustine Sales by Application (2027-2032) & (K Units) Table 58. Global Bendamustine Sales Market Share in Volume by Application (2027-2032) Table 59. Global Bendamustine Sales by Application (2027-2032) & (US$ Million) Table 60. Global Bendamustine Sales Market Share in Value by Application (2027-2032) Table 61. Global Bendamustine Price by Application (2027-2032) & (USD/Unit) Table 62. North America Bendamustine Sales by Application (2021-2026) & (K Units) Table 63. North America Bendamustine Sales by Application (2021-2026) & (US$ Million) Table 64. Europe Bendamustine Sales by Application (2021-2026) & (K Units) Table 65. Europe Bendamustine Sales by Application (2021-2026) & (US$ Million) Table 66. Asia-Pacific Bendamustine Sales by Application (2021-2026) & (K Units) Table 67. Asia-Pacific Bendamustine Sales by Application (2021-2026) & (US$ Million) Table 68. Latin America Bendamustine Sales by Application (2021-2026) & (K Units) Table 69. Latin America Bendamustine Sales by Application (2021-2026) & (US$ Million) Table 70. Middle East and Africa Bendamustine Sales by Application (2021-2026) & (K Units) Table 71. Middle East and Africa Bendamustine Sales by Application (2021-2026) & (US$ Million) Table 72. Teva Company Information Table 73. Teva Business Overview Table 74. Teva Bendamustine Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 75. Teva Bendamustine Product Portfolio Table 76. Teva Recent Development Table 77. Eisai Company Information Table 78. Eisai Business Overview Table 79. Eisai Bendamustine Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 80. Eisai Bendamustine Product Portfolio Table 81. Eisai Recent Development Table 82. Eagle Pharmaceuticals Company Information Table 83. Eagle Pharmaceuticals Business Overview Table 84. Eagle Pharmaceuticals Bendamustine Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 85. Eagle Pharmaceuticals Bendamustine Product Portfolio Table 86. Eagle Pharmaceuticals Recent Development Table 87. MundiPharma Company Information Table 88. MundiPharma Business Overview Table 89. MundiPharma Bendamustine Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 90. MundiPharma Bendamustine Product Portfolio Table 91. MundiPharma Recent Development Table 92. Mylan Company Information Table 93. Mylan Business Overview Table 94. Mylan Bendamustine Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 95. Mylan Bendamustine Product Portfolio Table 96. Mylan Recent Development Table 97. Natco Pharma Company Information Table 98. Natco Pharma Business Overview Table 99. Natco Pharma Bendamustine Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 100. Natco Pharma Bendamustine Product Portfolio Table 101. Natco Pharma Recent Development Table 102. Emcure Company Information Table 103. Emcure Business Overview Table 104. Emcure Bendamustine Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 105. Emcure Bendamustine Product Portfolio Table 106. Emcure Recent Development Table 107. Miracalus Pharma Company Information Table 108. Miracalus Pharma Business Overview Table 109. Miracalus Pharma Bendamustine Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 110. Miracalus Pharma Bendamustine Product Portfolio Table 111. Miracalus Pharma Recent Development Table 112. North America Bendamustine Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 113. North America Bendamustine Sales by Country (2021-2026) & (K Units) Table 114. North America Bendamustine Sales Market Share by Country (2021-2026) Table 115. North America Bendamustine Sales Forecast by Country (2027-2032) & (K Units) Table 116. North America Bendamustine Sales Market Share Forecast by Country (2027-2032) Table 117. North America Bendamustine Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 118. North America Bendamustine Market Size by Country (2021-2026) & (US$ Million) Table 119. North America Bendamustine Market Share by Country (2021-2026) Table 120. North America Bendamustine Market Size Forecast by Country (2027-2032) & (US$ Million) Table 121. North America Bendamustine Market Share Forecast by Country (2027-2032) Table 122. Europe Bendamustine Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 123. Europe Bendamustine Sales by Country (2021-2026) & (K Units) Table 124. Europe Bendamustine Sales Market Share by Country (2021-2026) Table 125. Europe Bendamustine Sales Forecast by Country (2027-2032) & (K Units) Table 126. Europe Bendamustine Sales Market Share Forecast by Country (2027-2032) Table 127. Europe Bendamustine Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 128. Europe Bendamustine Market Size by Country (2021-2026) & (US$ Million) Table 129. Europe Bendamustine Market Share by Country (2021-2026) Table 130. Europe Bendamustine Market Size Forecast by Country (2027-2032) & (US$ Million) Table 131. Europe Bendamustine Market Share Forecast by Country (2027-2032) Table 132. Asia-Pacific Bendamustine Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 133. Asia-Pacific Bendamustine Sales by Country (2021-2026) & (K Units) Table 134. Asia-Pacific Bendamustine Sales Market Share by Country (2021-2026) Table 135. Asia-Pacific Bendamustine Sales Forecast by Country (2027-2032) & (K Units) Table 136. Asia-Pacific Bendamustine Sales Market Share Forecast by Country (2027-2032) Table 137. Asia-Pacific Bendamustine Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 138. Asia-Pacific Bendamustine Market Size by Country (2021-2026) & (US$ Million) Table 139. Asia-Pacific Bendamustine Market Share by Country (2021-2026) Table 140. Asia-Pacific Bendamustine Market Size Forecast by Country (2027-2032) & (US$ Million) Table 141. Asia-Pacific Bendamustine Market Share Forecast by Country (2027-2032) Table 142. Latin America Bendamustine Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 143. Latin America Bendamustine Sales by Country (2021-2026) & (K Units) Table 144. Latin America Bendamustine Sales Market Share by Country (2021-2026) Table 145. Latin America Bendamustine Sales Forecast by Country (2027-2032) & (K Units) Table 146. Latin America Bendamustine Sales Market Share Forecast by Country (2027-2032) Table 147. Latin America Bendamustine Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 148. Latin America Bendamustine Market Size by Country (2021-2026) & (US$ Million) Table 149. Latin America Bendamustine Market Share by Country (2021-2026) Table 150. Latin America Bendamustine Market Size Forecast by Country (2027-2032) & (US$ Million) Table 151. Latin America Bendamustine Market Share Forecast by Country (2027-2032) Table 152. Middle East and Africa Bendamustine Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 153. Middle East and Africa Bendamustine Sales by Country (2021-2026) & (K Units) Table 154. Middle East and Africa Bendamustine Sales Market Share by Country (2021-2026) Table 155. Middle East and Africa Bendamustine Sales Forecast by Country (2027-2032) & (K Units) Table 156. Middle East and Africa Bendamustine Sales Market Share Forecast by Country (2027-2032) Table 157. Middle East and Africa Bendamustine Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 158. Middle East and Africa Bendamustine Market Size by Country (2021-2026) & (US$ Million) Table 159. Middle East and Africa Bendamustine Market Share by Country (2021-2026) Table 160. Middle East and Africa Bendamustine Market Size Forecast by Country (2027-2032) & (US$ Million) Table 161. Middle East and Africa Bendamustine Market Share Forecast by Country (2027-2032) Table 162. Key Raw Materials Table 163. Raw Materials Key Suppliers Table 164. Bendamustine Distributors List Table 165. Bendamustine Customers List Table 166. Research Programs/Design for This Report Table 167. Authors List of This Report Table 168. Secondary Sources Table 169. Primary Sources List of Figures Figure 1. Bendamustine Image Figure 2. Global Bendamustine Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Bendamustine Market Size (2021-2032) & (US$ Million) Figure 4. Global Bendamustine Sales (2021-2032) & (K Units) Figure 5. 25mg Injection Image Figure 6. Global 25mg Injection Sales YoY Growth (2021-2032) & (K Units) Figure 7. 100mg Injection Image Figure 8. Global 100mg Injection Sales YoY Growth (2021-2032) & (K Units) Figure 9. Others Image Figure 10. Global Others Sales YoY Growth (2021-2032) & (K Units) Figure 11. Global Bendamustine Market Size Overview by Type (2021-2032) & (US$ Million) Figure 12. Global Bendamustine Market Share by Type 2025 VS 2032 Figure 13. North America Bendamustine Sales Market Share in Volume by Type in 2025 Figure 14. North America Bendamustine Sales Market Share in Value by Type in 2025 Figure 15. Europe Bendamustine Sales Market Share in Volume by Type in 2025 Figure 16. Europe Bendamustine Sales Market Share in Value by Type in 2025 Figure 17. Asia-Pacific Bendamustine Sales Market Share in Volume by Type in 2025 Figure 18. Asia-Pacific Bendamustine Sales Market Share in Value by Type in 2025 Figure 19. Latin America Bendamustine Sales Market Share in Volume by Type in 2025 Figure 20. Latin America Bendamustine Sales Market Share in Value by Type in 2025 Figure 21. Middle East and Africa Bendamustine Sales Market Share in Volume by Type in 2025 Figure 22. Middle East and Africa Bendamustine Sales Market Share in Value by Type in 2025 Figure 23. Global Top 5 and 10 Bendamustine Players Market Share by Revenue in 2025 Figure 24. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 25. Chronic Lymphocytic Leukemia Image Figure 26. Global Chronic Lymphocytic Leukemia Sales YoY Growth (2021-2032) & (K Units) Figure 27. Multiple Myeloma Image Figure 28. Global Multiple Myeloma Sales YoY Growth (2021-2032) & (K Units) Figure 29. Non-Hodgkin's Lymphoma Image Figure 30. Global Non-Hodgkin's Lymphoma Sales YoY Growth (2021-2032) & (K Units) Figure 31. Global Bendamustine Market Size Overview by Application (2021-2032) & (US$ Million) Figure 32. Global Bendamustine Market Share by Application 2025 VS 2032 Figure 33. North America Bendamustine Sales Market Share in Volume by Application in 2025 Figure 34. North America Bendamustine Sales Market Share in Value by Application in 2025 Figure 35. Europe Bendamustine Sales Market Share in Volume by Application in 2025 Figure 36. Europe Bendamustine Sales Market Share in Value by Application in 2025 Figure 37. Asia-Pacific Bendamustine Sales Market Share in Volume by Application in 2025 Figure 38. Asia-Pacific Bendamustine Sales Market Share in Value by Application in 2025 Figure 39. Latin America Bendamustine Sales Market Share in Volume by Application in 2025 Figure 40. Latin America Bendamustine Sales Market Share in Value by Application in 2025 Figure 41. Middle East and Africa Bendamustine Sales Market Share in Volume by Application in 2025 Figure 42. Middle East and Africa Bendamustine Sales Market Share in Value by Application in 2025 Figure 43. North America Bendamustine Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 44. North America Bendamustine Sales Share by Country: 2021 VS 2025 VS 2032 Figure 45. North America Bendamustine Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 46. North America Bendamustine Market Share by Country: 2021 VS 2025 VS 2032 Figure 47. Europe Bendamustine Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 48. Europe Bendamustine Sales Share by Country: 2021 VS 2025 VS 2032 Figure 49. Europe Bendamustine Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 50. Europe Bendamustine Market Share by Country: 2021 VS 2025 VS 2032 Figure 51. Asia-Pacific Bendamustine Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 52. Asia-Pacific Bendamustine Sales Share by Country: 2021 VS 2025 VS 2032 Figure 53. Asia-Pacific Bendamustine Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 54. Asia-Pacific Bendamustine Market Share by Country: 2021 VS 2025 VS 2032 Figure 55. Latin America Bendamustine Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 56. Latin America Bendamustine Sales Share by Country: 2021 VS 2025 VS 2032 Figure 57. Latin America Bendamustine Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 58. Latin America Bendamustine Market Share by Country: 2021 VS 2025 VS 2032 Figure 59. Middle East and Africa Bendamustine Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 60. Middle East and Africa Bendamustine Sales Share by Country: 2021 VS 2025 VS 2032 Figure 61. Middle East and Africa Bendamustine Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 62. Middle East and Africa Bendamustine Market Share by Country: 2021 VS 2025 VS 2032 Figure 63. Bendamustine Value Chain Figure 64. Key Raw Materials Price Figure 65. Manufacturing Cost Structure Figure 66. Bendamustine Production Mode & Process Figure 67. Direct Comparison with Distribution Share Figure 68. Distributors Profiles Figure 69. Years Considered Figure 70. Research Process Figure 71. Key Executives Interviewed

Scope & coverage.

Types
  • 25mg Injection
  • 100mg Injection
  • Others
Applications
  • Chronic Lymphocytic Leukemia
  • Multiple Myeloma
  • Non-Hodgkin's Lymphoma
Companies covered
  • Teva
  • Eisai
  • Eagle Pharmaceuticals
  • MundiPharma
  • Mylan
  • Natco Pharma
  • Emcure
  • Miracalus Pharma

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Bendamustine Market Size Estimates and Forecasts (2021-2032)
  4. 1.2.2 Global Bendamustine Sales Estimates and Forecasts (2021-2032)
  5. 1.3 Bendamustine Market by Type
  6. 1.3.1 25mg Injection
  7. 1.3.2 100mg Injection
  8. 1.3.3 Others
  9. 1.4 Global Bendamustine Market Size by Type
  10. 1.4.1 Global Bendamustine Market Size Overview by Type (2021-2032)
  11. 1.4.2 Global Bendamustine Historic Market Size Review by Type (2021-2026)
  12. 1.4.3 Global Bendamustine Forecasted Market Size by Type (2027-2032)
  13. 1.5 Key Regions Market Size by Type
  14. 1.5.1 North America Bendamustine Sales Breakdown by Type (2021-2026)
  15. 1.5.2 Europe Bendamustine Sales Breakdown by Type (2021-2026)
  16. 1.5.3 Asia-Pacific Bendamustine Sales Breakdown by Type (2021-2026)
  17. 1.5.4 South America Bendamustine Sales Breakdown by Type (2021-2026)
  18. 1.5.5 Middle East and Africa Bendamustine Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
  1. 2.1 Bendamustine Industry Trends
  2. 2.2 Bendamustine Industry Drivers
  3. 2.3 Bendamustine Industry Opportunities and Challenges
  4. 2.4 Bendamustine Industry Restraints
3 Market Competitive Landscape by Company
  1. 3.1 Global Top Players by Bendamustine Revenue (2021-2026)
  2. 3.2 Global Top Players by Bendamustine Sales (2021-2026)
  3. 3.3 Global Top Players by Bendamustine Price (2021-2026)
  4. 3.4 Global Bendamustine Industry Company Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Bendamustine Major Company Production Sites & Headquarters
  6. 3.6 Global Bendamustine Company, Product Type & Application
  7. 3.7 Global Bendamustine Company Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Bendamustine Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Bendamustine Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Bendamustine Tier 1, Tier 2, and Tier 3
4 Bendamustine Regional Status and Outlook
  1. 4.1 Global Bendamustine Market Size and CAGR by Region: 2021 VS 2025 VS 2032
  2. 4.2 Global Bendamustine Historic Market Size by Region
  3. 4.2.1 Global Bendamustine Sales in Volume by Region (2021-2026)
  4. 4.2.2 Global Bendamustine Sales in Value by Region (2021-2026)
  5. 4.2.3 Global Bendamustine Sales (Volume & Value), Price and Gross Margin (2021-2026)
  6. 4.3 Global Bendamustine Forecasted Market Size by Region
  7. 4.3.1 Global Bendamustine Sales in Volume by Region (2027-2032)
  8. 4.3.2 Global Bendamustine Sales in Value by Region (2027-2032)
  9. 4.3.3 Global Bendamustine Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 Bendamustine by Application
  1. 5.1 Bendamustine Market by Application
  2. 5.1.1 Chronic Lymphocytic Leukemia
  3. 5.1.2 Multiple Myeloma
  4. 5.1.3 Non-Hodgkin's Lymphoma
  5. 5.2 Global Bendamustine Market Size by Application
  6. 5.2.1 Global Bendamustine Market Size Overview by Application (2021-2032)
  7. 5.2.2 Global Bendamustine Historic Market Size Review by Application (2021-2026)
  8. 5.2.3 Global Bendamustine Forecasted Market Size by Application (2027-2032)
  9. 5.3 Key Regions Market Size by Application
  10. 5.3.1 North America Bendamustine Sales Breakdown by Application (2021-2026)
  11. 5.3.2 Europe Bendamustine Sales Breakdown by Application (2021-2026)
  12. 5.3.3 Asia-Pacific Bendamustine Sales Breakdown by Application (2021-2026)
  13. 5.3.4 South America Bendamustine Sales Breakdown by Application (2021-2026)
  14. 5.3.5 Middle East and Africa Bendamustine Sales Breakdown by Application (2021-2026)
6 Company Profiles
  1. 6.1 Teva
  2. 6.1.1 Teva Company Information
  3. 6.1.2 Teva Business Overview
  4. 6.1.3 Teva Bendamustine Sales, Revenue and Gross Margin (2021-2026)
  5. 6.1.4 Teva Bendamustine Product Portfolio
  6. 6.1.5 Teva Recent Developments
  7. 6.2 Eisai
  8. 6.2.1 Eisai Company Information
  9. 6.2.2 Eisai Business Overview
  10. 6.2.3 Eisai Bendamustine Sales, Revenue and Gross Margin (2021-2026)
  11. 6.2.4 Eisai Bendamustine Product Portfolio
  12. 6.2.5 Eisai Recent Developments
  13. 6.3 Eagle Pharmaceuticals
  14. 6.3.1 Eagle Pharmaceuticals Company Information
  15. 6.3.2 Eagle Pharmaceuticals Business Overview
  16. 6.3.3 Eagle Pharmaceuticals Bendamustine Sales, Revenue and Gross Margin (2021-2026)
  17. 6.3.4 Eagle Pharmaceuticals Bendamustine Product Portfolio
  18. 6.3.5 Eagle Pharmaceuticals Recent Developments
  19. 6.4 MundiPharma
  20. 6.4.1 MundiPharma Company Information
  21. 6.4.2 MundiPharma Business Overview
  22. 6.4.3 MundiPharma Bendamustine Sales, Revenue and Gross Margin (2021-2026)
  23. 6.4.4 MundiPharma Bendamustine Product Portfolio
  24. 6.4.5 MundiPharma Recent Developments
  25. 6.5 Mylan
  26. 6.5.1 Mylan Company Information
  27. 6.5.2 Mylan Business Overview
  28. 6.5.3 Mylan Bendamustine Sales, Revenue and Gross Margin (2021-2026)
  29. 6.5.4 Mylan Bendamustine Product Portfolio
  30. 6.5.5 Mylan Recent Developments
  31. 6.6 Natco Pharma
  32. 6.6.1 Natco Pharma Company Information
  33. 6.6.2 Natco Pharma Business Overview
  34. 6.6.3 Natco Pharma Bendamustine Sales, Revenue and Gross Margin (2021-2026)
  35. 6.6.4 Natco Pharma Bendamustine Product Portfolio
  36. 6.6.5 Natco Pharma Recent Developments
  37. 6.7 Emcure
  38. 6.7.1 Emcure Company Information
  39. 6.7.2 Emcure Business Overview
  40. 6.7.3 Emcure Bendamustine Sales, Revenue and Gross Margin (2021-2026)
  41. 6.7.4 Emcure Bendamustine Product Portfolio
  42. 6.7.5 Emcure Recent Developments
  43. 6.8 Miracalus Pharma
  44. 6.8.1 Miracalus Pharma Company Information
  45. 6.8.2 Miracalus Pharma Business Overview
  46. 6.8.3 Miracalus Pharma Bendamustine Sales, Revenue and Gross Margin (2021-2026)
  47. 6.8.4 Miracalus Pharma Bendamustine Product Portfolio
  48. 6.8.5 Miracalus Pharma Recent Developments
7 North America by Country
  1. 7.1 North America Bendamustine Sales by Country
  2. 7.1.1 North America Bendamustine Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 7.1.2 North America Bendamustine Sales by Country (2021-2026)
  4. 7.1.3 North America Bendamustine Sales Forecast by Country (2027-2032)
  5. 7.2 North America Bendamustine Market Size by Country
  6. 7.2.1 North America Bendamustine Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 7.2.2 North America Bendamustine Market Size by Country (2021-2026)
  8. 7.2.3 North America Bendamustine Market Size Forecast by Country (2027-2032)
8 Europe by Country
  1. 8.1 Europe Bendamustine Sales by Country
  2. 8.1.1 Europe Bendamustine Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 8.1.2 Europe Bendamustine Sales by Country (2021-2026)
  4. 8.1.3 Europe Bendamustine Sales Forecast by Country (2027-2032)
  5. 8.2 Europe Bendamustine Market Size by Country
  6. 8.2.1 Europe Bendamustine Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 8.2.2 Europe Bendamustine Market Size by Country (2021-2026)
  8. 8.2.3 Europe Bendamustine Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
  1. 9.1 Asia-Pacific Bendamustine Sales by Country
  2. 9.1.1 Asia-Pacific Bendamustine Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 9.1.2 Asia-Pacific Bendamustine Sales by Country (2021-2026)
  4. 9.1.3 Asia-Pacific Bendamustine Sales Forecast by Country (2027-2032)
  5. 9.2 Asia-Pacific Bendamustine Market Size by Country
  6. 9.2.1 Asia-Pacific Bendamustine Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 9.2.2 Asia-Pacific Bendamustine Market Size by Country (2021-2026)
  8. 9.2.3 Asia-Pacific Bendamustine Market Size Forecast by Country (2027-2032)
10 South America by Country
  1. 10.1 South America Bendamustine Sales by Country
  2. 10.1.1 South America Bendamustine Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 10.1.2 South America Bendamustine Sales by Country (2021-2026)
  4. 10.1.3 South America Bendamustine Sales Forecast by Country (2027-2032)
  5. 10.2 South America Bendamustine Market Size by Country
  6. 10.2.1 South America Bendamustine Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 10.2.2 South America Bendamustine Market Size by Country (2021-2026)
  8. 10.2.3 South America Bendamustine Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
  1. 11.1 Middle East and Africa Bendamustine Sales by Country
  2. 11.1.1 Middle East and Africa Bendamustine Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 11.1.2 Middle East and Africa Bendamustine Sales by Country (2021-2026)
  4. 11.1.3 Middle East and Africa Bendamustine Sales Forecast by Country (2027-2032)
  5. 11.2 Middle East and Africa Bendamustine Market Size by Country
  6. 11.2.1 Middle East and Africa Bendamustine Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 11.2.2 Middle East and Africa Bendamustine Market Size by Country (2021-2026)
  8. 11.2.3 Middle East and Africa Bendamustine Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
  1. 12.1 Bendamustine Value Chain Analysis
  2. 12.1.1 Bendamustine Key Raw Materials
  3. 12.1.2 Key Raw Materials Price
  4. 12.1.3 Raw Materials Key Suppliers
  5. 12.1.4 Manufacturing Cost Structure
  6. 12.1.5 Bendamustine Production Mode & Process
  7. 12.2 Bendamustine Sales Channels Analysis
  8. 12.2.1 Direct Comparison with Distribution Share
  9. 12.2.2 Bendamustine Distributors
  10. 12.2.3 Bendamustine Customers
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources
    8. 14.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst